Display options
Cite
Kong SH, Koo BK, Moon MK. Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes Metab J. 2017;41(2):152-153doi: 10.4093/dmj.2017.41.2.152.
Kong, S. H., Koo, B. K., & Moon, M. K. (2017). Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes & metabolism journal, 41(2), 152-153. https://doi.org/10.4093/dmj.2017.41.2.152
Kong, Sung Hye, et al. "Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)." Diabetes & metabolism journal vol. 41,2 (2017): 152-153. doi: https://doi.org/10.4093/dmj.2017.41.2.152
Kong SH, Koo BK, Moon MK. Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152. PMID: 28447443; PMCID: PMC5409003.
Copy Download .nbib Format: NLM
Share it on

Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).

Diabetes & metabolism journal

Sung Hye Kong, Bo Kyung Koo, Min Kyong Moon

Affiliations

  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  3. Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea. [email protected].

PMID: 28447443 PMCID: PMC5409003 DOI: 10.4093/dmj.2017.41.2.152

[No abstract available.]

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

  1. Diabetes Metab J. 2017 Feb;41(1):23-30 - PubMed
  2. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73 - PubMed
  3. Am J Cardiol. 2007 Feb 1;99(3):410-4 - PubMed
  4. Eur J Clin Pharmacol. 2015 Mar;71(3):329-40 - PubMed
  5. Clin Pharmacol Ther. 2005 Oct;78(4):330-41 - PubMed

Publication Types